RT Journal Article
SR Electronic
T1 Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.201679
DO 10.3899/jrheum.201679
A1 Leung, Ying Ying
A1 Orbai, Ana-Maria
A1 Tillett, William
A1 Ogdie, Alexis
A1 Eder, Lihi
A1 Goel, Niti
A1 Hojgaard, Pil
A1 Holland, Richard
A1 Mathew, Ashish J.
A1 Lindsay, Christine A.
A1 Antony, Anna
A1 Chau, Jeffrey
A1 Christensen, Robin
A1 Coates, Laura C.
A1 Mease, Philip J.
A1 Strand, Vibeke
A1 FitzGerald, Oliver
A1 de Wit, Maarten
A1 Callis Duffin, Kristina
A1 Gladman, Dafna D.
YR 2021
UL http://www.jrheum.org/content/early/2021/02/24/jrheum.201679.abstract
AB The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group provided updates at the 2020 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. Working groups were set up for the 4 prioritized domains: enthesitis, fatigue, structural damage, and physical function. Two instruments for measurement of physical function were provisionally endorsed: (1) the Health Assessment Questionnaire–Disability Index and (2) the physical functioning domain in the Medical Outcomes Study 36-item Short Form survey.